Kyle Lefkoff, Director at ARRAY BIOPHARMA INC (ARRY), sold 15,000 shares at $9.01 ($99K) on 2006-02-21, disclosed to the SEC on 2006-02-22.
Open-market sale of $99k ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,000 | $0 | 0.0% |
| 2 | $0.00 | 3,000 | $0 | 0.0% |
| 3 | $9.01 | 10,000 | $90K | 90.8% |
| 4 | $9.16 | 1,000 | $9K | 9.2% |
| Total | $6.62 avg | 15,000 | $99K | 100% |
| Filing → |
| ARRY | SELL | 2018-02-12 | $1.7M | — | Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |